 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Galena Settles Investor Lawsuits Following Successful RXi Spinout
June 14, 2012
Galena Settles Investor Lawsuits Following Successful RXi Spinout
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- RXi Gets Spun Out of Galena, Names New CEO as it Loses Its CSO
May 10, 2012 / Gene Silencing News - Galena Slapped with Third Investor Lawsuit Related to Planned RXi Spin Out
January 26, 2012 / Gene Silencing News - Galena Makes Payment to Investors to Settle Securities Litigation
March 29, 2012 / Gene Silencing News - Galena Hit with Fourth Investor Lawsuit Related to Planned RXi Spinout
February 9, 2012 / Gene Silencing News - RXi Q1 Loss Rises on Opko Deal Charge
May 16, 2013 / Gene Silencing News